The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Matt Biegler is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/08/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/11/2025 | OKUR | Buy Now | OnKure Therapeutics | $3.30 | 809.09% | Matt Biegler6% | $35 → $30 | Maintains | Outperform | Get Alert |
| 10/10/2024 | OKUR | Buy Now | OnKure Therapeutics | $3.30 | 960.61% | Matt Biegler6% | → $35 | Initiates | → Outperform | Get Alert |
